Román, Juan <br/><br/>
Evaluation of responsive gene expression as a sensitive and specific biomarker in patients with ulcerative colitis.  [electronic resource] 

 -  Inflammatory bowel diseases  Feb 2013 
 - 221-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1536-4844 
<br/><br/><label>Standard No.: </label>10.1002/ibd.23020  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aminosalicylic Acids--therapeutic use<br/>Anti-Inflammatory Agents, Non-Steroidal--therapeutic use<br/>Antigens, Differentiation--genetics<br/>Azo Compounds--therapeutic use<br/>CD18 Antigens--genetics<br/>Case-Control Studies<br/>Cohort Studies<br/>Colitis, Ulcerative--drug therapy<br/>Double-Blind Method<br/>Female<br/>Gene Expression Profiling<br/>Genetic Markers<br/>Humans<br/>Interleukin-2 Receptor alpha Subunit--genetics<br/>Logistic Models<br/>Male<br/>Mesalamine--therapeutic use<br/>Middle Aged<br/>Polymerase Chain Reaction<br/>Receptors, Interleukin-1 Type II--genetics<br/>Sensitivity and Specificity<br/>Severity of Illness Index<br/>Transcriptome<br/>Treatment Outcome